Viewing Study NCT05412966


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-21 @ 2:55 PM
Study NCT ID: NCT05412966
Status: COMPLETED
Last Update Posted: 2023-01-09
First Post: 2022-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence
Sponsor: Pear Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PEAR-002-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER_GOV View
None NIH View
None UNKNOWN View